The Food and Drug Administration approved Kynamro, a new drug that not only treats a rare inherited disorder, but does so using a technology that can shut off specific genes that cause disease.img width='1' height='1' src='http://rss.nytimes.com/c/34625/f/640346/s/2809157c/mf.gif' border='0'/br/br/a href="http://da.feedsportal.com/r/151885003585/u/0/f/640346/c/34625/s/2809157c/a2.htm"img src="http://da.feedsportal.com/r/151885003585/u/0/f/640346/c/34625/s/2809157c/a2.img" border="0"//aimg width="1" height="1" src="http://pi.feedsportal.com/r/151885003585/u/0/f/640346/c/34625/s/2809157c/a2t.img" border="0"/